Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2012-03-23Clinical Trial Update: Exendin-4 as a Treatment for Parkinson's Disease - Pilot Study [Phase 2]
The document concerns a Phase 2 pilot study evaluating Exendin-4 for Parkinson's disease. It notes the sponsor and that the trial status is …
-
CLINICAL_TRIALS research · 2012-03-19Clinical Trial Update: Multicenter Study on Fibrotic Valvular Heart Disease in Patients With Parkinson's Disease Treated With Dopamine Agonists
A multicenter clinical trial update investigating fibrotic valvular heart disease in patients with Parkinson's disease treated with dopamine…
-
CLINICAL_TRIALS trial_result · 2012-03-07Clinical Trial Update: Continuous Application of Lisuride in Parkinson's Disease by Subcutaneous Infusion [Phase 3]
Phase 3 trial evaluating continuous subcutaneous lisuride infusion for Parkinson's disease has completed.
-
CLINICAL_TRIALS trial_result · 2012-03-06Clinical Trial Update: Sensory Stimulation Effect on Movement Speed in Patients With Parkinson Disease [NA]
A completed clinical trial evaluating whether sensory stimulation affects movement speed in patients with Parkinson's disease.
-
FDA approval · 2012-02-23FDA Approved: ROPINIROLE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved a supplemental application for ropinirole from Glenmark Pharmaceuticals Inc., USA.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-02-22Clinical Trial Update: Long Term Follow-Up Study for rAAV-GAD Treated Subjects
Long-term follow-up results from subjects treated with rAAV-GAD in a Parkinson's disease trial.
-
CLINICAL_TRIALS trial_result · 2012-02-22Clinical Trial Update: Study of AAV-GAD Gene Transfer Into the Subthalamic Nucleus for Parkinson's Disease [Phase 2]
A Phase 2 trial evaluating AAV-GAD gene transfer into the subthalamic nucleus for Parkinson's disease has been terminated.
-
CLINICAL_TRIALS trial_result · 2012-02-20Clinical Trial Update: Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Apathy in Parkinson's Disease [NA]
This clinical trial evaluated repetitive transcranial magnetic stimulation (rTMS) for apathy in Parkinson's disease and has completed with r…
-
CLINICAL_TRIALS research · 2012-02-14Clinical Trial Update: Dementia Registry for Parkinson's Disease
A completed clinical trial registry study evaluating dementia in Parkinson's disease patients (Dementia Registry for Parkinson's Disease).
-
CLINICAL_TRIALS research · 2012-02-09Clinical Trial Update: Development of Cognitive Assessment Tools in Parkinson Disease [EARLY_Phase 1]
A completed early-phase study focused on developing cognitive assessment tools for Parkinson's disease.
-
CLINICAL_TRIALS trial_result · 2012-02-09Clinical Trial Update: A Study of Neurophysiologic Changes in Individuals With Parkinson's Disease
This clinical trial update notes the completion of a study on neurophysiologic changes in individuals with Parkinson's disease. The study wa…
-
CLINICAL_TRIALS research · 2012-02-09Clinical Trial Update: Genetic Study in Young Onset Parkinson's Disease
Clinical trial update describing a genetic study in young-onset Parkinson disease; the current status of the study is unknown.
-
CLINICAL_TRIALS trial_result · 2012-02-08Clinical Trial Update: Evaluation of [18F] FEPPA and PET Imaging as a Marker of Inflammation in Subjects With Neurological Conditions [Phase 1]
Phase 1 study evaluating the PET imaging tracer [18F] FEPPA as a marker of inflammation in subjects with Alzheimer's disease, Parkinson's di…
-
CLINICAL_TRIALS trial_result · 2012-02-07Clinical Trial Update: Effect of Deep Brain Stimulation on Gastrointestinal (GI) Motility [NA]
Update on a completed clinical trial evaluating whether deep brain stimulation affects gastrointestinal motility in Parkinson's disease.
-
CLINICAL_TRIALS trial_result · 2012-02-07Clinical Trial Update: Olfaction in Patients With Parkinson's Disease Following Treatment With Rasagiline [Phase 4]
Phase 4 clinical trial evaluating olfactory function in Parkinson's disease patients treated with rasagiline; the study status is completed.
-
FDA approval · 2012-02-07FDA Approved: ROPINIROLE — Original Application (Marlex Pharmaceuticals Inc)
FDA approved a generic version of ropinirole (Original Application) by Marlex Pharmaceuticals Inc for use in Parkinson's disease and restles…
-
CLINICAL_TRIALS trial_result · 2012-01-31Clinical Trial Update: Effectiveness of an Active Lifestyle Promotion Program for Patients With Parkinson's Disease [Phase 3]
A Phase 3 trial evaluating an Active Lifestyle Promotion Program for Parkinson's disease has completed.
-
CLINICAL_TRIALS trial_result · 2012-01-27Clinical Trial Update: Deep Brain Stimulation (DBS) Frequency Effects on Gait in Parkinson's Disease(PD) [Phase 1, Phase 2]
A Phase 1/2 study evaluated how different deep brain stimulation frequencies impact gait in Parkinson disease; the trial has completed and r…
-
CLINICAL_TRIALS research · 2012-01-24Clinical Trial Update: Validation of the Hebrew Version of the Montreal Affective Voices.
This update reports validation of the Hebrew version of the Montreal Affective Voices in a study involving individuals with Parkinson's dise…
-
CLINICAL_TRIALS trial_result · 2012-01-24Clinical Trial Update: Study to Observe the Effect of Mirapex ER® Once-daily (QD) Versus Twice-daily (BID) [Phase 4]
Phase 4 clinical trial comparing once-daily Mirapex ER to twice-daily dosing in Parkinson's disease; status is unknown in the document.
-
FDA approval · 2012-01-18FDA Approved: AMANTADINE HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for amantadine hydrochloride from Upsher-Smith Laboratories, expanding its regulatory status for thi…
-
FDA approval · 2012-01-18FDA Approved: AMANTADINE HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application for amantadine hydrochloride submitted by Chartwell RX, LLC, authorizing changes to this drug's …
-
CLINICAL_TRIALS research · 2012-01-13Clinical Trial Update: Mapping and Manipulating the Emotional Territories of the Basal Ganglia in PD Patients [NA]
This entry notes a Hadassah Medical Organization clinical trial in Parkinson's disease exploring the basal ganglia's emotional circuits, wit…
-
CLINICAL_TRIALS trial_result · 2012-01-12Clinical Trial Update: Behavioral Therapy to Treat Urinary Incontinence in Parkinson's Disease [NA]
A completed clinical trial evaluating behavioral therapy to treat urinary incontinence in people with Parkinson's disease.
-
CLINICAL_TRIALS trial_result · 2012-01-02Clinical Trial Update: Laser Light Visual Cueing for Freezing of Gait in Parkinson's Disease [Phase 3]
Phase 3 trial evaluating laser light visual cueing to reduce freezing of gait in Parkinson's disease has completed.